MRI-Derived Radiomics Features of Hepatic Fat Predict Metabolic States in Individuals without Cardiovascular Disease.
Diabetes mellitus
Fatty liver
Magnetic resonance Imaging
Metabolic syndrome
Journal
Academic radiology
ISSN: 1878-4046
Titre abrégé: Acad Radiol
Pays: United States
ID NLM: 9440159
Informations de publication
Date de publication:
11 2021
11 2021
Historique:
received:
11
03
2020
revised:
23
06
2020
accepted:
25
06
2020
pubmed:
18
8
2020
medline:
24
11
2021
entrez:
18
8
2020
Statut:
ppublish
Résumé
To investigate radiomics features of hepatic fat as potential biomarkers of type 2 diabetes mellitus (T2DM) and metabolic syndrome (MetS) in individuals without overt cardiovascular disease, and benchmarking against hepatic proton density fat fraction (PDFF) and the body mass index (BMI). This study collected liver radiomics features of 310 individuals that were part of a case-controlled imaging substudy embedded in a prospective cohort. Individuals had known T2DM (n = 39; 12.6 %) and MetS (n = 107; 34.5 %) status, and were divided into stratified training (n = 232; 75 %) and validation (n = 78; 25 %) sets. Six hundred eighty-four MRI radiomics features were extracted for each liver volume of interest (VOI) on T On the validation set, the radiomics RF models predicted T2DM with AUROC of 0.835 and Accuracy Hepatic radiomics features may serve as potential imaging biomarkers for T2DM and MetS.
Identifiants
pubmed: 32800693
pii: S1076-6332(20)30408-6
doi: 10.1016/j.acra.2020.06.030
pii:
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
S1-S10Informations de copyright
Copyright © 2020 The Association of University Radiologists. Published by Elsevier Inc. All rights reserved.